-
1
-
-
67649823667
-
Pharmacological therapy for atrial fibrillation: Current options and new agents
-
10.1517/13543780902773410. 19278302
-
Pharmacological therapy for atrial fibrillation: current options and new agents. MN Viswanathan RL Page, Expert Opin Investig Drugs 2009 18 4 417 431 10.1517/13543780902773410 19278302
-
(2009)
Expert Opin Investig Drugs
, vol.18
, Issue.4
, pp. 417-431
-
-
Viswanathan, M.N.1
Page, R.L.2
-
2
-
-
77949284423
-
Atrial fibrillation: The new epidemic of the ageing world
-
Atrial Fibrillation: The New Epidemic of the Ageing World. WS Aronow M Banach, J Atrial Fibrillation 2009 1 337 361
-
(2009)
J Atrial Fibrillation
, vol.1
, pp. 337-361
-
-
Aronow, W.S.1
Banach, M.2
-
3
-
-
0038509861
-
Heart failure complicated by atrial fibrillation: Mechanistic, prognostic, and therapeutic implications
-
10.1177/107424840300800203. 12808483
-
Heart failure complicated by atrial fibrillation: mechanistic, prognostic, and therapeutic implications. GC Grönefeld SH Hohnloser, J Cardiovasc Pharmacol Ther 2003 8 2 107 113 10.1177/107424840300800203 12808483
-
(2003)
J Cardiovasc Pharmacol Ther
, vol.8
, Issue.2
, pp. 107-113
-
-
Grönefeld, G.C.1
Hohnloser, S.H.2
-
4
-
-
72249116784
-
Postoperative atrial fibrillation - What do we really know?
-
19538179
-
Postoperative atrial fibrillation - what do we really know? M Banach A Kourliouros KM Reinhart S Benussi DP Mikhailidis M Jahangiri W Baker A Galanti J Rysz JA Camm CM White O Alfieri, Curr Vasc Pharmacol 2010 19538179
-
(2010)
Curr Vasc Pharmacol
-
-
Banach, M.1
Kourliouros, A.2
Reinhart, K.M.3
Benussi, S.4
Mikhailidis, D.P.5
Jahangiri, M.6
Baker, W.7
Galanti, A.8
Rysz, J.9
Camm, J.A.10
White, C.M.11
Alfieri, O.12
-
5
-
-
34748868947
-
The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy
-
10.1007/s00059-007-3045-5. 17882369
-
The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy. JP Kaski P Elliott ESC Working Group, Herz 2007 32 6 446 51 10.1007/s00059-007-3045-5 17882369
-
(2007)
Herz
, vol.32
, Issue.6
, pp. 446-51
-
-
Kaski, J.P.1
Elliott, P.2
-
6
-
-
34347346007
-
Autoimmunological features in inflammatory cardiomyopathy
-
10.1007/s00392-007-0524-x. 17503113
-
Autoimmunological features in inflammatory cardiomyopathy. A Kellwellis-Opara A Dörner WC Poller M Noutsias U Kühl HP Schultheiss M Pauschinger, Clin Res Cardiol 2007 96 469 480 10.1007/s00392-007-0524-x 17503113
-
(2007)
Clin Res Cardiol
, vol.96
, pp. 469-480
-
-
Kellwellis-Opara, A.1
Dörner, A.2
Poller, W.C.3
Noutsias, M.4
Kühl, U.5
Schultheiss, H.P.6
Pauschinger, M.7
-
7
-
-
74549144559
-
Atrial fibrillation in congestive heart failure
-
10.1097/CRD.0b013e3181c21cff. 20010337
-
Atrial fibrillation in congestive heart failure. J Seiler WG Stevenson, Cardiol Rev 2010 18 1 38 50 10.1097/CRD.0b013e3181c21cff 20010337
-
(2010)
Cardiol Rev
, vol.18
, Issue.1
, pp. 38-50
-
-
Seiler, J.1
Stevenson, W.G.2
-
8
-
-
75149122548
-
The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy
-
19946241
-
The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy. A Bielecka-Dabrowa JH Goch DP Mikhailidis J Rysz M Maciejewski M Banach, Med Sci Monit 2009 15 12 S12 23 19946241
-
(2009)
Med Sci Monit
, vol.15
, Issue.12
-
-
Bielecka-Dabrowa, A.1
Goch, J.H.2
Mikhailidis, D.P.3
Rysz, J.4
MacIejewski, M.5
Banach, M.6
-
10
-
-
0035122832
-
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: Involvement of angiotensin AT1 receptor expression and Rac1 GTPase
-
11179461
-
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. S Wassmann U Laufs AT Baumer K Müller Ch Konkol H Sauer M Böhm G Nickenig, Mol Pharmacol 2001 59 646 654 11179461
-
(2001)
Mol Pharmacol
, vol.59
, pp. 646-654
-
-
Wassmann, S.1
Laufs, U.2
Baumer, A.T.3
Müller, K.4
Konkol, C.5
Sauer, H.6
Böhm, M.7
Nickenig, G.8
-
11
-
-
33645747309
-
The Rac and Rho hall of fame: A decade of hypertrophic signaling hits
-
10.1161/01.RES.0000216039.75913.9e. 16574914
-
The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. JH Brown DP Del Re MA Sussman, Circ Res 2006 98 730 742 10.1161/01.RES.0000216039. 75913.9e 16574914
-
(2006)
Circ Res
, vol.98
, pp. 730-742
-
-
Brown, J.H.1
Del Re, D.P.2
Sussman, M.A.3
-
12
-
-
73449087969
-
Cholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes?
-
Cholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes? G Wainwright L Mascitelli MR Goldstein, Arch Med Sci 2009 5 3 289 295
-
(2009)
Arch Med Sci
, vol.5
, Issue.3
, pp. 289-295
-
-
Wainwright, G.1
Mascitelli, L.2
Goldstein, M.R.3
-
13
-
-
0036322869
-
Isoprenoids as mediators of the biological effects of statins
-
12163444
-
Isoprenoids as mediators of the biological effects of statins. JK Liao, J Clin Invest 2002 110 285 288 12163444
-
(2002)
J Clin Invest
, vol.110
, pp. 285-288
-
-
Liao, J.K.1
-
14
-
-
0346736491
-
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
-
10.1172/JCI1500. 9637705
-
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. O Hernandez-Perera D Perez-Sala J Navarro-Antolin R Snchez-Pascuala G Hernndez C Díaz S Lamas, J Clin Invest 1998 101 2711 2719 10.1172/JCI1500 9637705
-
(1998)
J Clin Invest
, vol.101
, pp. 2711-2719
-
-
Hernandez-Perera, O.1
Perez-Sala, D.2
Navarro-Antolin, J.3
Snchez-Pascuala, R.4
Hernndez, G.5
Díaz, C.6
Lamas, S.7
-
15
-
-
33750606896
-
Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention
-
10.1097/01.fjc.0000246150.52382.07. 17086091
-
Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. J Kowalski M Barylski M Banach J Grycewicz R Irzmaski L Pawlicki, J Cardiovasc Pharmacol 2006 48 4 143 7 10.1097/01.fjc.0000246150.52382.07 17086091
-
(2006)
J Cardiovasc Pharmacol
, vol.48
, Issue.4
, pp. 143-7
-
-
Kowalski, J.1
Barylski, M.2
Banach, M.3
Grycewicz, J.4
Irzmaski, R.5
Pawlicki, L.6
-
16
-
-
0032584177
-
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
-
9537338
-
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. U Laufs V La Fata J Plutzky, Circulation 1998 97 1129 1135 9537338
-
(1998)
Circulation
, vol.97
, pp. 1129-1135
-
-
Laufs, U.1
La Fata, V.2
Plutzky, J.3
-
17
-
-
10844242066
-
Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure
-
10.1136/hrt.2003.027110. 15604328
-
Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure. D Tousoulis C Antoniades E Bosinakou M Kotsopoulou C Tsioufis C Tentolouris A Trikas C Pitsavos C Stefanadis, Heart 2005 91 27 31 10.1136/hrt.2003.027110 15604328
-
(2005)
Heart
, vol.91
, pp. 27-31
-
-
Tousoulis, D.1
Antoniades, C.2
Bosinakou, E.3
Kotsopoulou, M.4
Tsioufis, C.5
Tentolouris, C.6
Trikas, A.7
Pitsavos, C.8
Stefanadis, C.9
-
18
-
-
0015116634
-
Enzyme-linked immunosorbent assay (ELISA). Quantative assay of immunoglobulin G
-
10.1016/0019-2791(71)90454-X
-
Enzyme-linked immunosorbent assay (ELISA). Quantative assay of immunoglobulin G. E Engvall P Perlman, Immunochemistry 1971 9 871 874 10.1016/0019-2791(71)90454-X
-
(1971)
Immunochemistry
, vol.9
, pp. 871-874
-
-
Engvall, E.1
Perlman, P.2
-
19
-
-
34250190254
-
Significance of permanent atrial fibrillation in idiopathic dilated cardiomyopathy
-
10.1016/j.ancard.2007.02.003. 17572169
-
Significance of permanent atrial fibrillation in idiopathic dilated cardiomyopathy. B Brembilla-Perrot O Marçon F Chometon L Groben O Claudon A Terrier de la Chaise P Louis H Blangy N Sadoul O Selton S Ammar M Abbas Y Juillière, Ann Cardiol Angeiol (Paris) 2007 56 3 107 110 10.1016/j.ancard.2007.02.003 17572169
-
(2007)
Ann Cardiol Angeiol (Paris)
, vol.56
, Issue.3
, pp. 107-110
-
-
Brembilla-Perrot, B.1
Marçon, O.2
Chometon, F.3
Groben, L.4
Claudon, O.5
De La Chaise, A.T.6
Louis, P.7
Blangy, H.8
Sadoul, N.9
Selton, O.10
Ammar, S.11
Abbas, M.12
Juillière, Y.13
-
20
-
-
34247125688
-
Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy
-
10.1016/j.ijcard.2006.03.090. 17027102
-
Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy. FI Parthenakis AP Patrianakos EI Skalidis GF Diakakis EA Zacharis G Chlouverakis IK Karalis PE Vardas, Int J Cardiol 2007 118 2 206 214 10.1016/j.ijcard.2006.03.090 17027102
-
(2007)
Int J Cardiol
, vol.118
, Issue.2
, pp. 206-214
-
-
Parthenakis, F.I.1
Patrianakos, A.P.2
Skalidis, E.I.3
Diakakis, G.F.4
Zacharis, E.A.5
Chlouverakis, G.6
Karalis, I.K.7
Vardas, P.E.8
-
21
-
-
33749456748
-
Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure
-
16981052
-
Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure. I Wojtkowska B Sobkowicz WJ Musia M Kozuch, Kardiol Pol 2006 64 8 777 783 16981052
-
(2006)
Kardiol Pol
, vol.64
, Issue.8
, pp. 777-783
-
-
Wojtkowska, I.1
Sobkowicz, B.2
Musia, W.J.3
Kozuch, M.4
-
22
-
-
33847139750
-
Tachycardia-induced cardiomyopathy: Mechanisms of heart failure and clinical implications
-
17312430
-
Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications. L Cal E De Ruvo A Sette L Sciarra R Scioli F Sebastiani M Topai R Iulianella G Navone E Lioy F Gaita, J Cardiovasc Med (Hagerstown) 2007 8 3 138 143 17312430
-
(2007)
J Cardiovasc Med (Hagerstown)
, vol.8
, Issue.3
, pp. 138-143
-
-
Cal, L.1
De Ruvo, E.2
Sette, A.3
Sciarra, L.4
Scioli, R.5
Sebastiani, F.6
Topai, M.7
Iulianella, R.8
Navone, G.9
Lioy, E.10
Gaita, F.11
-
23
-
-
51549107210
-
Natriuretic peptides in cardiovascular diseases
-
10.2478/s11658-007-0046-6. 17965966
-
Natriuretic peptides in cardiovascular diseases. M Piechota M Banach A Jaco J Rysz, Cell Mol Biol Lett 2008 13 2 155 81 10.2478/s11658-007-0046-6 17965966
-
(2008)
Cell Mol Biol Lett
, vol.13
, Issue.2
, pp. 155-81
-
-
Piechota, M.1
Banach, M.2
Jaco, A.3
Rysz, J.4
-
24
-
-
26244432388
-
Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
10.1016/S0140-6736(05)67394-1. 16214597
-
Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. C Baigent A Keech PM Kearney L Blackwell G Buck C Pollicino A Kirby T Sourjina R Peto R Collins R Simes, Lancet 2005 366 1267 1278 10.1016/S0140-6736(05)67394-1 16214597
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
Blackwell, L.4
Buck, G.5
Pollicino, C.6
Kirby, A.7
Sourjina, T.8
Peto, R.9
Collins, R.10
Simes, R.11
-
25
-
-
33748572257
-
Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy
-
10.1016/j.jacc.2006.05.053. 16979011, DEFINITE Investigators
-
Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. JJ Goldberger H Subacius A Schaechter A Howard R Berger A Shalaby J Levine AH Kadish DEFINITE Investigators, J Am Coll Cardiol 2006 48 1228 1233 10.1016/j.jacc.2006.05.053 16979011
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 1228-1233
-
-
Goldberger, J.J.1
Subacius, H.2
Schaechter, A.3
Howard, A.4
Berger, R.5
Shalaby, A.6
Levine, J.7
Kadish, A.H.8
-
26
-
-
33746283135
-
Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction
-
10.1016/j.hrthm.2006.05.010. 16876733
-
Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. IR Hanna B Heeke H Bush L Brosius D King-Hageman SC Dudley Jr JF Beshai JJ Langberg, Heart Rhythm 2006 3 881 886 10.1016/j.hrthm.2006.05.010 16876733
-
(2006)
Heart Rhythm
, vol.3
, pp. 881-886
-
-
Hanna, I.R.1
Heeke, B.2
Bush, H.3
Brosius, L.4
King-Hageman, D.5
Jr D. C, S.6
Beshai, J.F.7
Langberg, J.J.8
-
27
-
-
36049042584
-
Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients - A pilot study
-
10.1016/j.cyto.2007.07.187. 17851087
-
Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients - a pilot study. F Streitner J Kuschyk C Veltmann M Brueckmann I Streitner J Brade M Neumaier T Bertsch B Schumacher M Borggrefe C Wolpert, Cytokine 2007 40 1 30 34 10.1016/j.cyto.2007.07.187 17851087
-
(2007)
Cytokine
, vol.40
, Issue.1
, pp. 30-34
-
-
Streitner, F.1
Kuschyk, J.2
Veltmann, C.3
Brueckmann, M.4
Streitner, I.5
Brade, J.6
Neumaier, M.7
Bertsch, T.8
Schumacher, B.9
Borggrefe, M.10
Wolpert, C.11
-
28
-
-
41149116161
-
Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients
-
18650968
-
Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. E Haugen LM Gan A Isic T Skommevik M Fu, Exp Clin Cardiol 2008 13 1 19 24 18650968
-
(2008)
Exp Clin Cardiol
, vol.13
, Issue.1
, pp. 19-24
-
-
Haugen, E.1
Gan, L.M.2
Isic, A.3
Skommevik, T.4
Fu, M.5
-
29
-
-
44149098471
-
Statins in the prevention of postoperative atrial fibrillation: Is there really no effect?
-
10.1016/j.ahj.2008.03.008. 18513502
-
Statins in the prevention of postoperative atrial fibrillation: is there really no effect? M Banach JH Goch M Ugurlucan G Mariscalco J Rysz, Am Heart J 2008 155 6 53 10.1016/j.ahj.2008.03.008 18513502
-
(2008)
Am Heart J
, vol.155
, Issue.6
, pp. 553
-
-
Banach, M.1
Goch, J.H.2
Ugurlucan, M.3
Mariscalco, G.4
Rysz, J.5
-
30
-
-
40849116122
-
Anti-arrhythmic effects of statins: A hypothesis remains to be tested
-
10.1016/j.hrthm.2008.01.033. 18362017
-
Anti-arrhythmic effects of statins: a hypothesis remains to be tested. HM Guo, Heart Rhythm 2008 5 4 511 2 10.1016/j.hrthm.2008.01.033 18362017
-
(2008)
Heart Rhythm
, vol.5
, Issue.4
, pp. 511-2
-
-
Guo, H.M.1
-
31
-
-
60249086418
-
The relationship between high-density lipoprotein, bacterial lipopolysaccharide, and tumour necrosis factor- in patients with acute decompensated heart failure
-
The relationship between high-density lipoprotein, bacterial lipopolysaccharide, and tumour necrosis factor- in patients with acute decompensated heart failure. AV Zimmermann W Doehner AV Pérez H Schmidt HD Volk SD Anker M Rauchhaus, Arch Med Sci 2008 4 4 380 385
-
(2008)
Arch Med Sci
, vol.4
, Issue.4
, pp. 380-385
-
-
Zimmermann, A.V.1
Doehner, W.2
Pérez, A.V.3
Schmidt, H.4
Volk, H.D.5
Anker, S.D.6
Rauchhaus, M.7
|